warning icon

COVID-19 DEW Report, powered by Reformulary®Read more

close

Latest From the
world of Reformulary

Reformulary Group launches drug coverage exception process
 
Learn More
Cannabis Standard Index brings much-needed clarity to medical cannabis
 
Learn More
Reformulary Group announces preferred pharmacy partnership with Rexall
 
Learn More
Reformulary Group launches Quality of Life tool for prescription drugs and cannabis
 
Learn More
Reformulary Group joins BlackNorth Initiative to combat anti-black racism in Canadian business
 
Learn More
Reformulary Group Announces Partnership with VIVO Cannabis
 
Learn More
Reformulary Group launches COVID-19 DEW Report
 
Learn More
New study underscores importance of medical cannabis rating system
 
Learn More
Reformulary 2019 Year in Review
 
Learn More
Cannabis Standard Insights, Issue #2 published by Reformulary Group
 
Learn More
CIX Canadian Innovation Exchange announced Reformulary Group as a CIX TOP 20 Early innovative Canad...
 
Learn More
Letter to the editor: Pharmacare – not all Canadians, not all drugs
 
Learn More